Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 150 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - pancreatic exocrine deficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 300 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine deficiency.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 400 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - granules gastro-resistant - 60.12 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - lactulose - oral solution - 3.335 g/5ml - osmotically acting laxatives - osmotically acting laxatives - constipation hepatic encephalopathy (he): treatment and prevention of hepatic coma or precoma

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol - film coated tablet - 2 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol hemihydrate - film coated tablet - 1 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension.